FDA Clears SOMATOM Drive CT System


Siemens Healthineers has announced that the Food and Drug Administration (FDA) has cleared the SOMATOM Drive computed tomography (CT) system. This new dual source scanner is designed to drive precision in diagnostic imaging across a wide range of clinical disciplines – from pediatrics and emergency medicine to cardiology and oncology – as well as deliver a new level of quality in patient care with the potential to reduce examination time, preparation, and follow-up care.

“Siemens Healthineers is proud to introduce the high-performance SOMATOM Drive dual source CT system, which provides our customers with the flexibility to deliver more precise imaging – and potentially further reduce  patient dose through the utilization of multiple KV settings,” says Douglas Ryan, Vice President of Computed Tomography at Siemens Healthineers North America.

The SOMATOM Drive CT system is equipped with the new Straton MX Sigma X-ray tubes and Sigma generators, which allow for more targeted beam focusing and enable examinations using high energy levels at low voltages. These lower voltages may allow clinicians to use less contrast, which can be burdensome for patients who are seriously ill or have reduced kidney function. And because the X-ray tube voltages of the SOMATOM Drive are adjustable in 10 kV increments ranging from 70 kV to 140 kV, clinicians can tailor the voltage and, therefore, the dose to each patient. Scanning at a lower kV level reduces patient radiation exposure.

This technology helps enable CT lung scans to be performed at an extremely low dose, which could prove beneficial for lung cancer screening. With this combination of low doses and high diagnostic reliability, the SOMATOM Drive is also ideal for spinal diagnostics and orthopedic examinations. Additionally, the scanner’s Dual Energy mode can help clinicians accurately differentiate between tissue and bone.